SEGALL BRYANT & HAMILL, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1006378
CHICAGO, IL
Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$18,414,774
+$1,413,657 QoQ
Shares Held
37,072
-2.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#276
of 1,735 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEGALL BRYANT & HAMILL, LLC holds $322,746,195 across 29 Biotechnology names. VRTX ranks #8 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
214,724 | $26,320,867 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
317,924 | $24,883,911 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
65,211 | $24,236,972 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
271,735 | $22,165,423 | |
| 5 | TECH |
BIO-TECHNE Corp
|
312,035 | $22,045,272 | |
| 6 | CYTK |
Cytokinetics Inc
|
257,063 | $21,899,196 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
178,980 | $20,953,188 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
37,072 | $18,414,774 |
All Filings in VRTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,414,774 | 37,072 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $17,001,117 | 38,073 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $18,052,341 | 39,819 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,045,882 | 40,971 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $18,844,425 | 42,328 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $25,609,162 | 52,822 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $22,645,834 | 56,235 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $26,893,251 | 57,825 | Shares | Sole | 2024-11-08 | |
| 2023-06-30 | $308,273 | 876 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $271,590 | 862 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $248,928 | 862 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $249,583 | 862 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $242,902 | 862 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $224,956 | 862 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $480,887 | 2,385 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $431,714 | 2,009 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $470,552 | 1,991 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $494,442 | 1,817 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $252,860 | 871 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $207,254 | 871 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||